Curis
CRIS
#10359
Rank
โ‚น1.76 B
Marketcap
โ‚น45.38
Share price
0.19%
Change (1 day)
-78.41%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): -โ‚น315.89

According to Curis's latest financial reports the company's current EPS (TTM) is -โ‚น351.21. In 2024 the company made an earnings per share (EPS) of -โ‚น672.76 an increase over its 2023 EPS that were of -โ‚น864.15.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น315.89-53.05%
2024-โ‚น672.76-22.15%
2023-โ‚น864.15-26.17%
2022-โ‚น1,17022.3%
2021-โ‚น956.98-25.37%
2020-โ‚น1,282-30.93%
2019-โ‚น1,857-2.02%
2018-โ‚น1,895
2016-โ‚น4,306-10%
2015-โ‚น4,785138.1%
2014-โ‚น2,01040%
2013-โ‚น1,435-25%
2012-โ‚น1,91466.67%
2011-โ‚น1,148

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น125.36-135.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น340.68-197.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น34.45-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚น299.53-185.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น372.27 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚น1,076 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น134.93-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA